# FDA Inspection 1137226 - Eli Lilly & Company - March 16, 2021

Source: https://www.keypedia.com/records/fda_inspections/eli-lilly-company/7f3b3b6d-ac7d-4e27-a39b-176d20d89825
Source feed: FDA_Inspections

> FDA Inspection 1137226 for Eli Lilly & Company on March 16, 2021. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1137226
- Company Name: Eli Lilly & Company
- Inspection Date: 2021-03-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1298628 - 2026-01-09](https://www.keypedia.com/records/fda_inspections/eli-lilly-company/2dba8d12-4ce7-4911-b7d2-d04cc01b2be0)
- [FDA Inspection 1298628 - 2026-01-09](https://www.keypedia.com/records/fda_inspections/eli-lilly-company/588c5618-399c-4fcd-8a5d-2b3129fb789a)
- [FDA Inspection 1270621 - 2025-05-20](https://www.keypedia.com/records/fda_inspections/eli-lilly-company/809cae3e-94ad-47cf-a116-8f4799dc570f)
- [FDA Inspection 1270621 - 2025-05-20](https://www.keypedia.com/records/fda_inspections/eli-lilly-company/fef8c0ae-2da9-4018-a496-4396a5db1b07)
- [FDA Inspection 1260339 - 2025-03-27](https://www.keypedia.com/records/fda_inspections/eli-lilly-company/fcdf8499-2933-4ba0-907d-711ccf9ded98)

Company: https://www.keypedia.com/companies/eli-lilly-company/fc56eed7-d261-4de3-865e-c2aa54162adf

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c